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ABSTRACT 
Clinical scorecards of risk factors associated with disease severity 
or mortality outcome are used by clinicians to make treatment 
decisions and optimize resources. This study develops an 
automated tool or framework based on evolutionary algorithms for 
the derivation of scorecards from clinical data. The techniques 
employed are based on the NSGA-II Multi-objective Optimization 
Genetic Algorithm (GA) which optimizes the Pareto-front of two 
clinically-relevant scorecard objectives, size and accuracy. Three 
automated methods are presented which improve on previous 
manually derived scorecards. The first is a hybrid algorithm which 
uses the GA for feature selection and a decision tree for scorecard 
generation. In the second, the GA generates the full scorecard. The 
third is an extended full scoring system in which the GA also 
generates the scorecard scores. In this system combinations of 
features and thresholds for each scorecard point are selected by the 
algorithm and the evolutionary process is used to discover near-
optimal Pareto-fronts of scorecards for exploration by expert 
decision makers. This is shown to produce scorecards that improve 
upon a human derived example for C.Difficile, an important 
infection found globally in communities and hospitals, although the 
methods described are applicable to any disease where the required 
data is available. 
CCS CONCEPTS 
• Computing methodologies~Genetic algorithms • Mathematics 
of computing~Mixed discrete-continuous optimization 
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1 INTRODUCTION 
Hospital admissions in the UK increased by 27.5% in the 10 years 
to March 2017 [1]. In an environment of limited resources, this puts 
ever greater pressure on clinical staff to understand disease severity 
and prioritise treatment for those cases that are at greatest risk of 
mortality. Clinical scorecards are an efficient method of assisting 
clinicians to stratify patients according to risk using evidence 
drawn from datasets of previous patient outcomes. A scorecard 
contains a (usually small) set of clinical measurements that are 
assigned a score, with higher scores usually indicating increased 
risk of mortality, or severity of disease. The most widely used 
scorecard is known as CURB-65. This is used to determine the risk 
posed to patients who are suffering from pneumonia and is defined 
as [2]: 
• Confusion (Abbreviated Mental Test score ≤ 8) 
• Blood Urea Nitrogen > 7 mmol/l (19 mg/dL) 
• Respiratory rate ≥ 30 breaths per minute 
• Blood pressure: 
Systolic BP < 90 mmHg or Diastolic BP ≤ 60 mmHg 
• Age ≥ 65 
1 point is awarded for each of these five parameters and summed 
to provide an estimate of likelihood of mortality. The likelihood 
increases with the score from 0.6% at score 0 to 27.8% at score 5. 
By using readily available clinical measurements, this score allows 
for treatment to be prioritised to those most at risk. 




To be effective, scorecards need to be accurate. They also need 
to be simple to implement by clinicians, to allow for accurate 
manual scoring in a high pressure clinical environment. As such, 
clinical scorecards should contain as few variables as possible for 
clinicians to measure and score, whilst providing the highest 
accuracy possible in terms of predicting mortality, to allow for 
differential allocation of limited treatment resources. In this paper 
we demonstrate the first use of multi-objective evolutionary 
algorithms to develop a Pareto-front of potential scorecards for 
experts to select from. The methodology could be applied to any 
appropriate disease with sufficient clinical data, however, the 
system is demonstrated here on real-world C.Difficile data as a case 
study. 
1.1 C.Difficile 
Butt et al [3] derived a clinical scorecard of risk factors associated 
with mortality outcome using manually applied univariate and 
multivariate analysis. The data used in that study was a set of real-
world data from a UK hospital of 245 patients suffering from 
C.Difficile. The data consisted of 30 parameters that are routinely 
collected on admission to hospital when C.Difficile is suspected. 
“C.Diff” is an antibiotic exposure related form of gastroenteritis 
that is associated with a high morbidity and mortality. Caused by 
Clostridium Difficile, it can be difficult to assess severity clinically. 
We use the same data in this study to develop a method for the 
automatic derivation of clinical scorecards for C.Diff. 
1.2 Scorecard Derivation from Data 
The creation of scorecards is usually accomplished through the 
analysis of a dataset of patient variables (features) coupled with 
disease severity or mortality outcomes. The scorecard will then 
usually be created by a process of manual interrogation of the data, 
coupled with the use of various computational tools to determine 
feature importance within the dataset. A two-step process is 
required to determine a scorecard: firstly the identification of a set 
of relevant features from the data; and secondly the application of 
a scoring mechanism. The scorecard is then usually assessed for 
accuracy by calculating a receiver operating characteristic (ROC) 
curve with each scoring point evaluated for false positive and false 
negative rates. The area under the ROC curve (AUC) is the standard 
accuracy reporting measure. 
Although no single established methodology for the elucidation 
of scorecards exists, a common approach is to rank the features in 
order of their correlation with the outcome and then add each 
feature into the scorecard until an acceptable accuracy level has 
been found. In [3], the approach used was based on decision tree 
feature importance, where the top features were discovered by an 
algorithmic approach. These features were then used to create a 
scorecard manually by exploring the various potential 
combinations of points scored with outcome accuracy on a training 
set. This was then tested on hold-out datasets and a validation 
cohort from another hospital. The 4-feature scorecard for 
C.Difficile which was derived using this method is shown in Table 
1. 
The scorecard shown in Table 1 gave an AUC of 0.754 on the 
training data set. Note that the last condition required both feature 
conditions to be true for a point to be awarded. This was found to 
give a higher AUC than if both were scored separately. A simpler 
scorecard without Respiratory Rate was also tested since the 
validation cohort data did not include this feature. This gave an 
AUC of 0.704 on the training data and an AUC of 0.653 on the 
validation data. Note that the Outcome used in [3] was “all 
mortality” and missing data scored 0. Here, the Outcome is “30-
day mortality” and scorecards were not scored if any scorecard 
features were missing from the data. For this modified outcome 
with the training data set, the AUC obtained for the scorecard in 
Table 1 is 0.784. 
Table 1: The clinical scorecard devised in Butt et al [3] 




Serum albumin levels (g/L) ≤ 24.5 1 0 
C-reactive protein (mg/L) > 228 1 0 
Respiratory rate (resps/min) 
and white cell count (103/mcL) 
> 17 
> 12 1 0 
 
In this work, we have used a multi-objective optimisation 
algorithm to automate the process of scorecard derivation from 
data: EMOCS (Evolutionary Multi-Objective Clinical Scorecard) 
system. We compare this with the human-based approach described 
above. To our knowledge, this is the first time that an MOEA has 
been used in this way, generating Pareto-fronts of scorecard size vs 
accuracy (in this case measured as the AUC). This approach has 
several advantages over existing methods: 
• The full trade-off of scorecard size vs accuracy can be 
discovered. Clinicians can investigate the trade-off between 
simplicity of use and the accuracy provided; 
• Interactions between variables can be captured. The EMOCS 
method can investigate the combinatorial effect of combining 
features within a scorecard, in contrast to the greedy 
approaches usually used; 
• More intricate scoring mechanisms can be explored. A single 
score of 1 for each feature is usually used in scorecard 
generation, whereas other scoring mechanisms can be 
automatically explored by the EMOCS approach; 
• The system provides full automation of scorecard generation 
from a dataset and can be applied to any disease dataset that 
has clinical features and severity or mortality outcomes. 
1.2 Previous Work 
With improvements in computational and machine learning 
techniques over the past few years, there have been a number of 
studies that have used evolutionary algorithms for data mining 
clinical data. Examples include [4] who used an evolutionary 
algorithm to find feature subsets in clinical data. This is most 
closely related to the first of the approaches described below, 
although the authors in [4] did not go on to create a clinical 
scorecard. [5–7] used an evolutionary algorithm in combination 
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 3 
with other methods to perform classification on clinical data taken 
for a range of purposes. The key difference between these 
approaches and the proposed work is that the previous work creates 
methods for classifying patients into sufferers and non-sufferers 
whereas this work develops a particular set of features, combined 
into a scorecard designed to determine risk of mortality arising 
from the disease. Furthermore, this approach uses multi-objective 
optimization to explore the trade-off between scorecard size and 
accuracy. Although multi-objective approaches have been used for 
prediction (e.g. [8]), this represents a different use case to that 
described here. Therefore this is, to the best of our knowledge, the 
first time that evolutionary algorithms have been applied to the 
discovery of scorecards from clinical data. 
The remainder of this paper is organized as follows: in Section 
2 the EMOCS methodology is described; in Section 3 results are 
shown for a cohort of 245 C.Diff patients; in Section 4 conclusions 
are drawn and future research directions are explored. 
2 METHODOLOGY 
The application of evolutionary algorithms to this problem presents 
several possibilities of the integration of evolution and machine 
learning tools. In this work, three approaches have been developed, 
with the influence of evolution increasing from feature selector to 
the derivation of complete scorecard: 
• EMO as a Feature Selector: In this approach the 
evolutionary algorithm acts as a feature selector ‘wrapper’ 
around a fast decision tree approach. Scores are allocated on a 
simple 1 point per feature basis; 
• EMO as a Scorecard Generator: In this approach the EA is 
required to select the features, operators and thresholds for the 
scorecard (effectively replacing the decision tree). Scores are 
still allocated on a simple 1 point basis; 
• EMO as a Complete Scoring System: As above, but scoring 
systems of greater complexity are permitted, allowing for 
multiple points to be awarded to more important features 
within a card. 
The EMOCS system uses the well-known NSGA-II algorithm 
[9] as the basis for the work described here. This work was carried 
out on an i7-6600U Windows® 7 laptop and an i7-6700 ubuntu 
workstation within the R [10] statistical software environment. 
Although NSGA-II implementations are available which can take 
customised chromosome types, the R package ‘nsga2R’ [11] was 
used in this study, which requires real valued chromosomes. The 
encoding is described fully in Section 2.3. The following sections 
describe in more detail the objectives used, and the three 
approaches described above. 
2.1 Objective Functions 
All three algorithm variants use the same two objective 
calculations: 
• Area Under the ROC Curve (AUC) (Maximised): This is a 
standard measure used in many fields including scorecard 
generation that measures a system’s ability to balance true and 
false positives for a number of decision points. In the case of 
scorecards with a single point allocated per feature, the 
number of points on the ROC curve is equal to the number of 
features in the scorecard. If multiple points are allowed per 
feature then the number of points on the ROC curve increases 
accordingly. The true and false positive rates for each 
successive point are assessed and used to create the AUC 
curve; 
• Features Used (Minimised): This is a simple cardinal measure 
of the number of features used to build the scorecard. This 
could be replaced by a measure of scorecard complexity, 
defined by clinicians (see future work). 
2.2 EMO as Feature Selector 
In this hybrid method, the chromosome only represents the feature 
selection part of scorecard generation. For a given set of features, a 
decision tree is used to determine operators and thresholds for each 
feature. The scorecard is then constructed and scored. This 
determines the objectives passed back to the nsga2R routine. 
The chromosome is constructed as for the full chromosome, 
shown below in Figure 1, however, only the first ‘Variable’ part is 
encoded. 
The decision tree used here is the “Fast and Frugal Tree” R 
package (FFTrees) [12, 13]. The advantage of this package, apart 
from being fast, is that it is frugal. That is, it produces decision trees 
which have a single leaf and further decision at each node. A further 
advantage of this routine is that it can generate a number of trees 
with a range of sensitivity and specificity. The tree used to generate 
the scorecard is that with the greatest balanced or weighted 
accuracy, as determined by the FFTrees routine. Parameters can be 
set, however, to modify how this is decided. Here, the default is 
used for which both balanced and weighted accuracy are equal to 
the average of the sensitivity and specificity. 
The FFTrees algorithm returns the collection of decisions which 
make up the chosen tree. Although the decision tree applies the 
conditions in a defined order, all of the conditions are used in the 
scorecard with equal weight. 1 point is assigned to “Score True” 
and 0 to “Score False”. 
2.3 EMO as Scorecard Generator 
The description here is for the chromosome used in the scorecard 
generator and the full scoring system. The methodology is as 
follows. See also, Figure 1 and Table 2. 
The chromosome represents feature selection, operators and 
thresholds. The scorecard is constructed from the chromosome with 
a score of 1 per feature allocated to “Score True”. “Score False” is 
always set to 0. This scorecard is then scored to determine the 
objectives passed back to the nsga2R routine. 
 
Figure 1: The full chromosome split into three for the 
different parts of the scorecard entries. 




The chromosome is split into three equal sections. The first 
section encodes the feature selection and score. The middle section 
encodes the operator, and the final section encodes the feature 
threshold values. 
A lower and upper bound is provided for each element of the 
chromosome, as indicated by the “Real Range” in Table 2. Note 
that many of the intervals are half open. In order to exclude the 
upper bound from parameters which map to integers, the upper 
bounds are the required integer upper bounds, less a real tolerance. 
This tolerance is given by √𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚  where 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚  is the smallest 
positive floating-point number 𝑥𝑥 such that 1 +  𝑥𝑥 ≠  1. 
The nsga2R routine generates a population of initial 
chromosomes with random values. Subsequent generations of 
chromosomes are generated by the routine from the previous 
generation using a series of cross-overs and mutations. In this study 
a population of 20 was used with standard values of 0.1 for the a 
mutation probability and 0.7 for the crossover probability. For each 
generation, scorecards are generated from the population of 
chromosomes and the objective functions are calculated. These 
objectives are used by nsga2R to determine which chromosomes 
should be kept in the population, and which cross-overs and 
mutations to be used. The first objective 𝑂𝑂𝑂𝑂𝑂𝑂1 = 1− 𝑎𝑎𝑎𝑎𝑎𝑎 
maximises the AUC. The second objective 𝑂𝑂𝑂𝑂𝑂𝑂2 = 𝛼𝛼 𝑛𝑛𝑣𝑣 +  𝛽𝛽 
minimises the number of variables 𝑛𝑛𝑣𝑣. 𝛼𝛼 = 0.1 and 𝛽𝛽 = −0.1 are 
chosen to map 𝑂𝑂𝑂𝑂𝑂𝑂2 to a similar range as 𝑂𝑂𝑂𝑂𝑂𝑂1. 
2.4 EMO as Complete Scoring System 
The chromosome represents feature selection, operators and 
thresholds as described above. Now, the feature selection includes 
the score to be allocated to that feature by setting a maximum score. 
The scorecard is constructed from the chromosome with the score 
allocated to “Score True”. “Score False” is always set to 0. The 
scorecard is then scored and the objectives passed back to the 
nsga2R routine. 
2.5 Validation 
To investigate the full potential of the methods, most of the 
experiments were performed using the full data set as a training set. 
However, to investigate the possibility of over fitting the data, a set 
of scorecard generation experiments was also performed using 5-
fold cross validation. Note that due to the nature of the data, this 




A series of experiments were performed with different random 
seeds for each of the three methods outlined in Section 2. 30 runs 
were performed for both the hybrid method and the scorecard 
generation system; 20 runs were performed for the more complex 
full scoring system due to increased computational complexity. 
Each run resulted in up to 20 unique scorecards, typically 6-9 for 
the hybrid method and 9-12 for both the scorecard and full scoring 
systems. Run times using a single core of an i7-6700 were typically 
50-70 minutes, 1½-5 hours and 5-7 hours, respectively. The 
hypervolume of the Pareto-front increased with the number of 
generations. Example Pareto-fronts are given in Figures 2 a)-c) for 
each method. Also indicated is the AUC for the previous scorecard 
given in Table 1, shown as a point on these plots. 
The results in Figure 2 show that the automated method is 
capable of discovering scorecards that dominate the human-derived 
scorecard shown by the point. The plots also reveal the expected 
relationship between the number of variables and the AUC for each 
scorecard. For each curve, there is no highly defined ‘knee’ but a 
scorecard of 4-6 points appears to provide a large degree of the 
available accuracy. The ability to use a differential scoring system 
appears to have some benefit, with higher AUCs possible for larger 
numbers of variables. However, there appears to be little difference 
in results between the hybrid method and full scorecard generator 
here, though the hybrid method may have computational 
advantages as described below. 
Figure 3 shows the mean of the normalised hypervolume against 
the number of generations for each series of 10 experiments. Here 
the hypervolume reference point is taken at auc=1 and number of 
features, or variables, nv=14. The shading gives the standard 
deviation of the experiments for that method. It is seen that within 
the experiments for a given method the variation in hypervolume is 
Table 2: Encoding the three parts of the full chromosome for the scorecard generator system (Score = 1) 
 and the full scoring system (Max Score > 1) 
Parameter Real Range Mapped Range Interpretation 
Variable 







(Max Score > 1) [0, (Max Score + 1) ) 0, 1, ... Max Score Not Selected/Score 




Extent of Data 
 
Extent of Data 
 
Real Value 
Integer Extent of Data Extent of Data Integer Value 
Factor [1, (No. of Levels + 1) ) 1, 2, ... No. of Levels Category 
Logical [0, 2) 0, 1 False/True 
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 5 
lowest for the hybrid method and greatest for the full scoring 
system. For a given set of features, the decision tree will always 
return the same set of conditions. So although the method explores 
the parameter space of the feature selection, no exploration is made 
of the condition operators or thresholds. In contrast, the two full 
scorecard methods explore the full scorecard parameter space. This 
exploration comes at a cost in time. The hybrid method is roughly 
six times faster than the full scoring system, with the scorecard 
generator method roughly 2-3 times faster. 
Comparing Figure 3 b) and c) the standard deviations show that 
allowing scores to vary in the full scoring system increases 
variations in the results obtained and tends to slow down 
convergence. This does, however, allow the method to produce 
scorecards with higher AUC values. The 4-feature scorecards with 
the highest AUC values obtained from the experiments presented 
here, are given in Table 3 for each method. 
The first feature in each scorecard is the same as for the previous 
scorecard in Table 1, though the conditions vary. Both the hybrid 
method and full scorecard system have two further features in 
common with the scorecard in Table 1, and the full scoring system 
has one further feature the same. In all cases, though, the conditions 
vary. The remaining two features from these methods, and the 
fourth feature from the hybrid method differ from Table 1. 
The full scoring system allocated the highest score of 3 points 
for “Score True” to the feature condition which is common to all 
scorecards. The next two feature conditions were given scores of 2 
points, and the last feature, which does not appear in any of the 
other scorecards, a score of 1 point. These scores reflect a measure 
of importance which can be assigned to the features concerned. 
The variations in the conditions for the same features reflects 
the exploration of parameter space which the methods employ. It 
also reflects the granularity of the data. It is striking that each of the 
scorecards use a number of similar features, although the thresholds 
used do vary significantly. The best scorecards derived by the 
evolutionary methods significantly exceed the performance of the 
human-derived scorecard on this data and increasing evolutionary 
‘freedom’ appears to improve the potential for this method to find 
scorecards with higher accuracy, although this may also result in 
greater overfitting (e.g. see Figure 5). 
The ROC curves corresponding to the scorecards in Table 3 are 
given in Figure 4. The increased number of points in Figure 4 c) 
compared with b) confirms that the full scoring system allows a 
greater choice of decision thresholds. Also shown in Figure 4 is the 
ROC curve for the scorecard from Table 1 for comparison. For each 
method presented here, the improvement in AUC is seen to result 
mainly from an improvement in true positive rates at mid to high 
false positive rates. 
Mean values for the AUC for each method are given in Table 4 
along with the standard deviations. The scorecard generator 
exceeds the performance of the hybrid system for all sizes of 
scorecard, and the full scoring system for scorecards with only two 
or three features. The full scoring system is marginally better than 
the scorecard generator for scorecards with 4 to 9 features, though 




Figure 2. Example Pareto-fronts for generations from 0 to 
2000 at intervals of 200. The lowest curves are for the random 
start points. The solid point shown in blue is for the scorecard 
of Table 1. The methods are: a) The hybrid method; b) the full 
scorecard generator; c) the full scoring system. 







Figure 3. The mean hypervolume for each generation at 
intervals of 200. The shading gives the standard deviation 
across the total runs for each method. The methods a)-c) are 




Figure 4. ROC curves for the 4-feature clinical scorecards 
given in Table 3 (solid line) and Table 1 (dashed line). The 
methods a)-c) are as for Table 3. 
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Table 3: The 4-feature clinical scorecards with highest AUC 
a) For the hybrid method: AUC=0.796 




Serum albumin levels (g/L) < 30 1 0 
C-reactive protein (mg/L) ≥ 90 1 0 
Respiratory rate (resps/min) ≥ 16 1 0 
Creatinine baseline (mg/DL) > 66 1 0 
 
b) For the full scorecard generator: AUC=0.844 




Serum albumin levels (g/L) < 31 1 0 
Respiratory rate (resps/min) > 14 1 0 
White cell count (103/mcL) > 16 1 0 
Diastolic BP (mmHg) < 61 1 0 
 
c) For the full scoring system: AUC=0.850 




Serum albumin levels (g/L) < 25 3 0 
White cell count (103/mcL) > 16 2 0 
Diastolic BP (mmHg) < 61 2 0 
Age (years) > 86 1 0 
 
3.2 Validation 
A series of 10 experiments were performed with 5-fold cross 
validation for the scorecard generation system described in Section 
2.3. Up to 20 unique scorecards (typically 9-12) were generated for 
each fold within each experiment. Run times using a single core of 
an i7-6700 were typically 1½-4½ hours per fold. Figure 5 shows 
Testing AUC against Training AUC for all of the resulting 
scorecards. The number of features, or variables, on the given 
scorecard is indicated by the symbol and colour of each point. Mean 
values for the AUC for the training and testing datasets, averaged 
over all validation runs, are given in Table 5 along with the standard 
deviations. 
Some reduced performance is expected for the test data, 
especially given the small size of the test data sets. Figure 5 and 
Table 5 show that the greatest decline in performance occurs for 
scorecards with the greater number of features. This is consistent 
with the greater number of features over-fitting the training data. In 
contrast, many of the scorecards with smaller numbers of features 
show less of a decline in performance, or even improved 
performance, when tested against the test data sets. It is noticeable 
that the peak in the mean AUC for the test data occurs for 
scorecards with 4 features, followed closely by sizes of 5 and 3. 
This lends support to the accuracy of scorecards with smaller or 
moderate numbers of features, as discussed in Section 3.1. 
Scorecards of this size are also more suitable for clinical use. 
 
Figure 5. AUC for the test data sets against AUC for the 
training data sets for 5-fold cross validation. The number of 
variables indicates the number of scorecard features. The 
dotted line is a guide to the eye and indicates the identity 
Testing AUC = Training AUC. 
 
4 CONCLUSIONS AND FURTHER WORK 
All three methodologies presented here automatically produce 
viable scorecards from clinical data. Although the hybrid feature 
selection method explores a full range of features, it relies upon 
decision trees, a greedy method, to provide the test conditions for 
the scorecards. The scorecards produced consistently improve upon 
the manually derived scorecard. Further, clinical decision makers 
should be able to choose scorecards which give improved true 
positive rates without compromising false positive rates. 
The full scorecard method explores both the full range of 
features and the test conditions. The best AUC values for a given 
number of features improve upon the hybrid method, though there 
is a much greater variation within the results obtained. Similarly, 
the full scoring system is able to give improved results for most 
sizes of scorecard, though again with significant variation within 
the results obtained. 
The full scoring system shows a further improvement in 
performance through the use of differential scores for each feature. 
This increase in AUC could be useful, although the number of 
points awarded per feature adds an additional level of complexity 
and therefore may not be applicable in all clinical situations. 
The automated systems presented here could be used for 
generating clinical scorecards from any suitable clinical data and 




represent the first such automated systems to the best of our 
knowledge. Future work will look at several areas. A simple 
extension will allow for interactions between features and 
incorporate a more realistic costing mechanism rather than simply 
taking the number of features as an objective. This will allow for a 
balance between the diagnostic power of the features and the cost 
in terms of simplicity of use, time and resources. Changes to the R 
code which applies the NSGA-II algorithm to the scorecard 
systems will be investigated in order to improve performance. In 
particular, the code could be developed to make better use of multi-
threading on multi-core systems. Further to work on the 
methodology itself, ways to present the results to the clinical 
practitioner (e.g. via an automated system) will also be considered. 
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